Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.
ADVANCED SEARCH
Log in
Top
Clinical & Experimental Metastasis
Published in: Clinical & Experimental Metastasis 8/1999

01-08-1999

Phenotypic and functional characteristics of tumour-derived microvascular endothelial cells

Authors: Giulio Alessandri, Renato G.S. Chirivi, Simona Fiorentini, Romina Dossi, Stefano Bonardelli, Stefano Maria Giulini, Gerardo Zanetta, Fabio Landoni, Pier Paolo Graziotti, Adolfo Turano, Arnoldo Caruso, Luciano Zardi, Raffaella Giavazzi, Maria Rosa Bani

Published in: Clinical & Experimental Metastasis | Issue 8/1999

Login to get access
Metadata
Title
Phenotypic and functional characteristics of tumour-derived microvascular endothelial cells
Authors
Giulio Alessandri
Renato G.S. Chirivi
Simona Fiorentini
Romina Dossi
Stefano Bonardelli
Stefano Maria Giulini
Gerardo Zanetta
Fabio Landoni
Pier Paolo Graziotti
Adolfo Turano
Arnoldo Caruso
Luciano Zardi
Raffaella Giavazzi
Maria Rosa Bani
Publication date
01-08-1999
Publisher
Kluwer Academic Publishers
Published in
Clinical & Experimental Metastasis / Issue 8/1999
Print ISSN: 0262-0898
Electronic ISSN: 1573-7276
DOI
https://doi.org/10.1023/A:1006738901839

Other articles of this Issue 8/1999

Clinical & Experimental Metastasis 8/1999 Go to the issue

OriginalPaper

Upregulation of vascular endothelial growth factor by cobalt chloride-simulated hypoxia is mediated by persistent induction of cyclooxygenase-2 in a metastatic human prostate cancer cell line

OriginalPaper

hMSH6 deficiency and inactivation of the αE-catenin invasion-suppressor gene in HCT-8 colon cancer cells

OriginalPaper

Ras-transfection up-regulated HaCaT cell migration: Inhibition by Marimastat

OriginalPaper

Integrin α4β1/VCAM-1 pathway mediates primary adhesion of RAW117 lymphoma cells to hepatic sinusoidal endothelial cells under flow

OriginalPaper

Functional cloning of ARM-1, an adhesion-regulating molecule upregulated in metastatic tumor cells

OriginalPaper

Soluble fibrin augments platelet/tumor cell adherence in vitro and in vivo, and enhances experimental metastasis
Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Watch now

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras
Prof. Fabrice Barlesi
Developed by: Springer Medicine
Image Credits